SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (358)2/7/2006 10:32:40 PM
From: tuck  Read Replies (2) | Respond to of 447
 
Old (2002), but interesting review of the patent literature for DP-IV inhibitors. Gives a good map of what the chemical structures are (for those who care/understand) and who the players are. It would appear the prodrug versions have an advantage in stability . . .

64.233.179.104

You can get this with better formatting for free at biomedcentral, but ya gotta register.

Cheers, Tuck